Ciphergen s SELDI Tech Helps Harvard Team Identify Likely Cancer Biomarker

Apr 08, 2002

NEW YORK, April 8 - Researchers at Harvard University have used protein-chip technology developed by Ciphergen Biosystems to identify a biomarker that might lead to faster detection of ovarian cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Try the Other Version

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

You Do Your Way

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

CRISPR Discussions

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

This Week in Science

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Main menu